USA – The FDA has temporarily halted trials of Gilead Sciences’ anti-CD47 antibody magrolimab in combination with azacitidine, citing an “apparent imbalance” in investigator-reported suspected unexpected serious adverse reactions (SUSARs)…
Read MoreTag: Trillium Therapeutics
Pfizer to pay US$6.7B in cash for Arena Pharmaceuticals acquisition
USA – Pfizer, the world’s largest pharmaceutical company, has announced that it had reached an agreement to buy drug developer Arena Pharmaceuticals for US$6.7 billion in cash. Pfizer will be…
Read More